Illumina Inc. (ILMN)
NASDAQ
Real-time Data
01:30 PM
Day's Range
254.0052 wk Range
88.00Overview - ILMN - Illumina Inc.
Key Statistics
Valuation
Enterprise Value
42.58B
P/E (Trailing)
‪50.84‬
P/E (Forward)
‪44.72‬
PEG Ratio
‪-6.31‬
Price / Sales (TTM)
‪9.17‬
Price / Book
‪14.52‬
EV / EBITDA
‪36.87‬
Profitability
Profit Margin
‪18.33%‬
Operating Margin
‪21.13%‬
Return on Assets
‪8.66%‬
Return on Equity
‪32.33%‬
Ownership
Shares Outstanding
151.00M
Float
149.77M
Short % of Shares Outstanding
‪11.47%‬
Held by Insiders
‪0.21%‬
Held by Institutions
‪106.42%‬
Price stats
Beta
‪1.46‬
50-Day Avg
‪217.37‬
200-Day Avg
‪162.01‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
21 analysts
Average price target
‪$ 198.89‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ILMN - Illumina Inc.
Peers - ILMN - Illumina Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
- ILMNNASDAQIllumina Inc.41.22BMarket Cap+63.00%52-week change50.85P/E (Trailing)‪18.33%‬Profit Margin
- NTRANASDAQNatera, Inc.59.14BMarket Cap+58.48%52-week change-269.84P/E (Trailing)‪-7.10%‬Profit Margin
- IDXXNASDAQIDEXX Laboratories, Inc.40.83BMarket Cap-21.10%52-week change37.14P/E (Trailing)‪25.03%‬Profit Margin
- GHNASDAQGuardant Health Inc.23.86BMarket Cap+64.35%52-week change-53.55P/E (Trailing)‪-38.32%‬Profit Margin
- MEDPNASDAQMedpace Holdings, Inc.16.86BMarket Cap+14.16%52-week change35.48P/E (Trailing)‪17.66%‬Profit Margin
- ICLRNASDAQICON plc12.50BMarket Cap-17.51%52-week change170.58P/E (Trailing)‪0.32%‬Profit Margin
- TWSTNASDAQTwist Bioscience Corporation12.12BMarket Cap+85.23%52-week change-140.79P/E (Trailing)‪-31.66%‬Profit Margin
Profile Summary - ILMN - Illumina Inc.
About
Illumina Inc. is a global genomics and life sciences company that develops DNA sequencing and array-based technologies used to analyze genetic variation and biological function. Its products and systems support research, clinical testing, and applied markets across areas such as oncology, inherited and infectious…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
